Displaying drugs 26 - 50 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Serdexmethylphenidate | 499.52 C25H29N3O8 |  | A prodrug of the CNS stimulant dexmethylphenidate used as a first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD). | Centrally Acting Sympathomimetics |
| Fosdenopterin | 363.223 C10H14N5O8P |  | An exogenous form of cyclic pyranopterin monophosphate (cPMP) used as a replacement substrate in patients with molybdenum cofactor deficiency (MoCD) type A. | Various Alimentary Tract and Metabolism Products |
| Melphalan flufenamide | 498.42 C24H30Cl2FN3O3 |  | A melphalan prodrug used to treat relapsed or refractory multiple myeloma. | Nitrogen Mustard Analogues |
| Prasterone enantate | 400.603 C26H40O3 |  | An estrogen indicated for hormone replacement therapy in postmenopausal women. | 17-Ketosteroids / Adrenal Cortex Hormones / Androstanes / Androstenes / Androstenols / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / Ketosteroids / Steroids / Testosterone Congeners |
| Thallous chloride Tl-201 | 236.42 ClTl |  | A radioisotope indicated for cardiac perfusion scintigraphy | Diagnostic Radiopharmaceuticals |
| Lactobacillus delbrueckii bulgaricus | Not Annotated |  | Not Annotated | Probiotics |
| Birch bark extract | Not Available |  | A herbal medicinal product used to treat partial thickness wounds. | Anti-Inflammatory Agents / Anti-inflammatory Agents, Miscellaneous / Biological Products / Complex Mixtures / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inhibitors / Plant Preparations / Triterpenes / Wound Healing |
| Mobocertinib | 585.709 C32H39N7O4 |  | An oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Tyrosine Kinase Inhibitors |
| Rezafungin | 1226.411 C63H85N8O17 |  | An echinocandin antifungal indicated in patients over 18 years old who have limited or no alternative options for the treatment of candidemia and invasive candidiasis. | Antifungal Agents |
| Gallium-68 PSMA | 947.005 C44H62N6O17 |  | Not Annotated | Not Annotated |
| Olutasidenib | 354.79 C18H15ClN4O2 |  | An isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of patients with relapsed or refractory acute myeloid leukemia with a susceptible IDH1 mutation as detected by an FDA-approved test. | Antineoplastic Agents / BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inducers / Cytochrome P-450 CYP1A2 Inducers (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2B6 Inducers / Cytochrome P-450 CYP2B6 Inducers (strength unknown) / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Inducers / Cytochrome P-450 CYP2C8 Inducers (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Inducers / Cytochrome P-450 CYP2C9 Inducers (strength unknown) / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Substrates / Enzyme Inhibitors / Heterocyclic Compounds, Fused-Ring / Isocitrate dehydrogenase-1 (IDH1) inhibitors / Isocitrate Dehydrogenase-1 Inhibitors / MATE 1 Inhibitors / MATE 2 Inhibitors / MATE inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / OCT2 Inhibitors / P-glycoprotein inhibitors / Potential QTc-Prolonging Agents / QTc Prolonging Agents |
| Odevixibat | 740.93 C37H48N4O8S2 |  | An ileal sodium/bile acid cotransporter inhibitor indicated in the treatment of pruritus in patients with progressive familial intrahepatic cholestasis. | Ileal Bile Acid Transporter Inhibitor |
| Mitapivat | 450.56 C24H26N4O3S |  | A pyruvate kinase activator used to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency. | Sulfonamides |
| Maralixibat | 674.96 C40H56N3O4S |  | An ileal bile acid transporter inhibitor indicated to treat cholestatic pruritus in patients with Alagille syndrome. | Ileal Bile Acid Transporter Inhibitor |
| Leniolisib | 450.466 C21H25F3N6O2 |  | A phosphoinositide 3-kinase-delta inhibitor that is used to treat activated phosphoinositide 3-kinase delta syndrome. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Kinase Inhibitor / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein substrates |
| Iptacopan | 422.525 C25H30N2O4 |  | A factor B inhibitor used to treat paroxysmal nocturnal hemoglobinuria. | Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 Substrates / UGT1A1 Substrates / UGT1A3 substrates |
| Finerenone | 378.432 C21H22N4O3 |  | A nonsteroidal mineralocorticoid receptor antagonist indicated to lower the risk of eGFR decline, end stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure in chronic kidney disease associated with type 2 diabetes. | Nonsteroidal Mineralocorticoid-Receptor Antagonist |
| Atogepant | 603.525 C29H23F6N5O3 |  | An oral CGRP antagonist used for the preventative therapy of episodic migraine headaches. | Calcitonin Gene-Related Peptide Receptor Antagonists |
| Indocyanine green | 774.97 C43H47N2NaO6S2 |  | A diagnostic agent for vascular imagine and radiography of the eye, as well as liver function tests. | Coloring Agents / Diagnostic Dye / Indoles |
| Thenyldiamine | 261.39 C14H19N3S |  | An ingredient in products indicated to treat rhinitis caused by the common cold. | Not Annotated |
| Gallium Ga-68 gozetotide | 1011.909 C44H59GaN6O17 |  | A radiopharmaceutical agent used in the diagnosis of prostate-specific membrane antigen (PSMA) positive lesions in male patients during positron emission tomography. | Gallium Radioisotopes / Radioactive Diagnostic Agent / Radiopharmaceuticals |
| Berotralstat | 562.573 C30H26F4N6O |  | An inhibitor of plasma kallikrein used for prophylaxis of angioedema attacks in patients with hereditary angioedema. | Plasma Kallikrein Inhibitor / Serine Protease Inhibitors |
| Sodium camphorsulfonate | 254.28 C10H15NaO4S |  | Not Annotated | Not Annotated |
| Ferric glycerophosphate | 479.858 C8H18Fe2O12P2 |  | Not Annotated | Not Annotated |
| Ammonium carbonate | 96.086 CH8N2O3 |  | An expectorant indicated to treat a cough and phlegm. | Alkalies / Anions / Carbon Compounds, Inorganic / Carbonic Acid / Electrolytes / Ions |
Displaying drugs 26 - 50 of 2774 in total